NCT06698458 - Alpha Radiation Emitters Device for the Treatment of Pancreatic Cancer With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 17, 2025

Primary Completion Date

October 31, 2026

Study Completion Date

December 31, 2026

Conditions

Pancreatic CancerPancreatic AdenocarcinomaMetastatic Pancreatic Cancer

Interventions

DEVICE

Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT)

DaRT source will be inserted using endoscopy into the tumor. The sources release by recoil into the tumor short-lived alpha-emitting atoms

Trial Locations (16)

10016

RECRUITING

NYU Langone Health, New York

10075

NOT_YET_RECRUITING

Lenox hill Hospital, New York

10467

RECRUITING

Montefiore Medical Center, The Bronx

13326

RECRUITING

Bassett Healthcare Network, Cooperstown

30308

NOT_YET_RECRUITING

Emory University, Atlanta

32804

NOT_YET_RECRUITING

Advent Health Cancer Institute, Orlando

55905

NOT_YET_RECRUITING

Mayo Clinic Rochester, Rochester

75251

NOT_YET_RECRUITING

Texas Oncology, Houston

77054

NOT_YET_RECRUITING

Baylor College of Medicine, Houston

77089

RECRUITING

University Cancer and Diagnostic, Houston

85234

NOT_YET_RECRUITING

Banner MD Anderson Cancer Center, Gilbert

85258

NOT_YET_RECRUITING

Honor Health, Scottsdale

85338

NOT_YET_RECRUITING

City of Hope, Goodyear

90048

NOT_YET_RECRUITING

Cedars-Sinai, Los Angeles

Unknown

NOT_YET_RECRUITING

Jewish General Hospital, Montreal

RECRUITING

Hadassah Ein Kerem, Jerusalem